Cate Speake Selected Research

Elements

5/2014

Low HERV-K(C4) copy number is associated with type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cate Speake Research Topics

Disease

51	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2024 - 05/2014
13	Disease Progression 05/2024 - 01/2018
6	Inflammation (Inflammations) 05/2023 - 04/2013
5	COVID-19 05/2023 - 01/2021
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2017
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 05/2014
3	Infections 03/2022 - 01/2021
2	Human Influenza (Influenza) 07/2023 - 04/2013
2	Critical Illness (Critically Ill) 05/2023 - 01/2021
2	Pancreatitis 11/2022 - 01/2022
2	Hepatitis D 03/2022 - 01/2022
2	Hyperglycemia 01/2022 - 01/2019
2	Malaria 01/2016 - 01/2009
2	Neoplasms (Cancer) 01/2015 - 01/2014
1	Polydipsia 07/2023
1	Hypertension (High Blood Pressure) 07/2023
1	Polyuria 07/2023
1	Fibrosis (Cirrhosis) 05/2023
1	Rheumatoid Arthritis 01/2023
1	Myocarditis (Carditis) 01/2023
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023
1	Down Syndrome (Down's Syndrome) 12/2022
1	Pain (Aches) 11/2022
1	Insulin Resistance 01/2022
1	Multiple Sclerosis 01/2022
1	Congenital Hyperinsulinism 01/2020
1	Obesity 01/2019
1	Lupus Nephritis 01/2017
1	Melanoma (Melanoma, Malignant) 01/2014

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2015
14	AutoantibodiesIBA 05/2024 - 01/2018
12	Insulin (Novolin)FDA Link 10/2023 - 01/2018
10	AntigensIBA 10/2023 - 01/2016
8	EpitopesIBA 07/2023 - 01/2018
6	C-PeptideIBA 05/2024 - 11/2018
6	Proteins (Proteins, Gene)FDA Link 05/2023 - 01/2009
5	CytokinesIBA 12/2022 - 01/2020
5	ProinsulinIBA 01/2022 - 12/2018
4	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2022
3	AutoantigensIBA 07/2023 - 01/2020
3	VaccinesIBA 01/2023 - 01/2022
3	COVID-19 VaccinesIBA 01/2023 - 01/2022
3	mRNA VaccinesIBA 01/2023 - 01/2022
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2023
3	Interleukin-6 (Interleukin 6)IBA 12/2022 - 01/2021
3	InterferonsIBA 12/2022 - 04/2013
2	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2021
2	Neutralizing AntibodiesIBA 03/2022 - 01/2022
2	AntibodiesIBA 03/2022 - 01/2022
2	Peptides (Polypeptides)IBA 01/2022 - 01/2020
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2020
2	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 01/2019
2	Abatacept (Orencia)FDA Link 01/2019 - 11/2018
1	teplizumabIBA 01/2024
1	Alefacept (Amevive)FDA Link 11/2023
1	HLA-DR alpha-ChainsIBA 07/2023
1	Immunodominant EpitopesIBA 07/2023
1	preproinsulinIBA 07/2023
1	Blood Glucose (Blood Sugar)IBA 07/2023
1	Hemoglobins (Hemoglobin)IBA 07/2023
1	Blood Proteins (Serum Proteins)IBA 05/2023
1	golimumab FDA Link 01/2023
1	siltuximabIBA 11/2022
1	tocilizumab (atlizumab)FDA Link 11/2022
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2022
1	Interleukin-8 (Interleukin 8)IBA 11/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2022
1	Angiopoietin-2IBA 11/2022
1	ResistinIBA 11/2022
1	GlucokinaseIBA 01/2022
1	anti-GAD65 autoantibodyIBA 01/2022
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2021
1	Viral RNAIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2020
1	staphylococcal enterotoxin BIBA 01/2020
1	Insulin-Like PeptidesIBA 01/2020
1	GlycosaminoglycansIBA 01/2019
1	HLA-DR Antigens (HLA-DR)IBA 12/2018
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	Interleukin-2 (IL2)IBA 01/2017
1	Combined VaccinesIBA 01/2016
1	Complement C4 (Complement Component 4)IBA 05/2014
1	ElementsIBA 05/2014
1	HLA-DQB1 antigen (HLA DQB1)IBA 05/2014
1	Complement System Proteins (Complement)IBA 05/2014
1	Interferon Type IIBA 01/2014
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 04/2013
1	ProteomeIBA 01/2009

Therapy/Procedure

14	Therapeutics 01/2024 - 01/2019
4	Immunotherapy 01/2023 - 01/2014
2	Precision Medicine 10/2023 - 04/2023
1	Glycemic Control 01/2019
1	Immunomodulation 01/2019